CLINICAL TRIALS PROFILE FOR CEFEPIME HYDROCHLORIDE

All Clinical Trials for cefepime hydrochloride

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00020865 ↗	Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia	Unknown status	National Cancer Institute (NCI)	Phase 3	2001-09-01	RATIONALE: Levofloxacin may be effective in reducing fever and controlling other symptoms of neutropenia in patients who are being treated for cancer. It is not yet known whether levofloxacin is more effective than cefepime in reducing fever and controlling symptoms of neutropenia. PURPOSE: Randomized phase III trial to compare the effectiveness of levofloxacin with that of cefepime in reducing fever and controlling symptoms of neutropenia in patients who are being treated for cancer.
NCT00020865 ↗	Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia	Unknown status	Jonsson Comprehensive Cancer Center	Phase 3	2001-09-01	RATIONALE: Levofloxacin may be effective in reducing fever and controlling other symptoms of neutropenia in patients who are being treated for cancer. It is not yet known whether levofloxacin is more effective than cefepime in reducing fever and controlling symptoms of neutropenia. PURPOSE: Randomized phase III trial to compare the effectiveness of levofloxacin with that of cefepime in reducing fever and controlling symptoms of neutropenia in patients who are being treated for cancer.
NCT00044759 ↗	Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma	Completed	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3	1969-12-31	To compare the safety and efficacy of piperacillin/tazobactam (4 g/500 mg) administered intravenously every 6 hours to cefepime (2 g) administered intravenously every 8 hours for the empiric treatment of neutropenic fever in patients with a hematologic malignancy or lymphoma.
NCT00137787 ↗	Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases	Completed	Bayer	Phase 3	2005-04-01	The aim of this study is to investigate whether intravenous ciprofloxacin is as effective as cefepime for the initial treatment of febrile neutropenia developed in patients with hematologic diseases.
NCT00137787 ↗	Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases	Completed	Center for Supporting Hematology-Oncology Trials	Phase 3	2005-04-01	The aim of this study is to investigate whether intravenous ciprofloxacin is as effective as cefepime for the initial treatment of febrile neutropenia developed in patients with hematologic diseases.
NCT00358202 ↗	Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia	Completed	Elan Pharmaceuticals	Phase 4	2002-03-01	Randomized trial of nursing home residents with pneumonia to assess if intramuscular cefepime is a safe, efficacious, and cost-effective alternative to once daily intramuscular ceftriaxone for the treatment of elderly nursing home residents who develop pneumonia and do not require hospitalization.
NCT00358202 ↗	Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia	Completed	CPL Associates	Phase 4	2002-03-01	Randomized trial of nursing home residents with pneumonia to assess if intramuscular cefepime is a safe, efficacious, and cost-effective alternative to once daily intramuscular ceftriaxone for the treatment of elderly nursing home residents who develop pneumonia and do not require hospitalization.

Clinical Trial Conditions for cefepime hydrochloride

Condition Name

Condition Name for cefepime hydrochloride
Intervention	Trials
Acute Pyelonephritis	5
Febrile Neutropenia	5
Complicated Urinary Tract Infection	5
Sepsis	3

Condition MeSH

Condition MeSH for cefepime hydrochloride
Intervention	Trials
Infections	17
Communicable Diseases	15
Infection	14
Urinary Tract Infections	11

Clinical Trial Locations for cefepime hydrochloride

Trials by Country

Trials by Country for cefepime hydrochloride
Location	Trials
United States	73
Spain	10
India	8
Poland	8
Brazil	6

Trials by US State

Trials by US State for cefepime hydrochloride
Location	Trials
Texas	10
California	7
New York	5
Florida	5
Pennsylvania	4

Clinical Trial Progress for cefepime hydrochloride

Clinical Trial Phase

Clinical Trial Phase for cefepime hydrochloride
Clinical Trial Phase	Trials
Phase 4	14
Phase 3	20
Phase 2/Phase 3	1

Clinical Trial Status

Clinical Trial Status for cefepime hydrochloride
Clinical Trial Phase	Trials
Completed	27
Not yet recruiting	10
Terminated	8

Clinical Trial Sponsors for cefepime hydrochloride

Sponsor Name

Sponsor Name for cefepime hydrochloride
Sponsor	Trials
Wockhardt	6
M.D. Anderson Cancer Center	5
Venatorx Pharmaceuticals, Inc.	4

Sponsor Type

Sponsor Type for cefepime hydrochloride
Sponsor	Trials
Other	60
Industry	37
NIH	5